Sylke Hoehnel-Ka

Dr. Sylke Hoehnel-Ka

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2011 in Nature Methods
Verified
Journal Article
Closed access
SGSamy Gobaa
Samy Gobaa
SHSylke Hoehnel-Ka
Sylke Hoehnel-Ka
MRMarta Roccio
Marta Roccio
ANAndrea Negro
Andrea Negro
SKStefan Kobel
Stefan Kobel
MLMatthias P Lutolf
Matthias P Lutolf

21 December 2015 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
CNCraig S. Nowell
Craig S. Nowell
POPascal D. Odermatt
Pascal D. Odermatt
LALuca Azzolin
Luca Azzolin
SHSylke Hoehnel-Ka
Sylke Hoehnel-Ka
EWErwin F. Wagner
Erwin F. Wagner
FRFreddy Radtke
Freddy Radtke

8 July 2022 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
SGSonja Giger
Sonja Giger
MHMoritz Hofer
Moritz Hofer
MMMarijana Miljkovic-Licina
Marijana Miljkovic-Licina
SHSylke Hoehnel-Ka
Sylke Hoehnel-Ka
NBNathalie Brandenberg
Nathalie Brandenberg
MLMatthias Lutolf
Matthias Lutolf
In many leukemia patients, a poor prognosis is attributed either to the development of chemotherapy resistance by leukemic stem cells (LSCs) or to the inefficient engraftment of transplanted hematopoietic stem/progenitor cells (HSPCs) into the bone marrow (BM). Here, we build a 3D in vitro model system of bone marrow organoids (BMOs) that recapitulate several structural and cellular components of native BM. These organoids are formed in a high-throughput manner from the aggregation of endothelial and mesenchymal cells within hydrogel microwells. Accordingly, the mesenchymal compartment shows partial maintenance of its self-renewal and multilineage potential, while endothelial cells self-organize into an interconnected vessel-like network. Intriguingly, such an endothelial compartment enhances the recruitment of HSPCs in a chemokine ligand/receptor-dependent manner, reminiscent of HSPC homing behavior in vivo. Additionally, we also model LSC migration and nesting in BMOs, thus highlighting the potential of this system as a well accessible and scalable preclinical model for candidate drug screening and patient-specific assays.

1 January 2015 in Integrative Biology
Verified
Journal Article
Closed access
PDF file
SGS. Gobaa
S. Gobaa
SHSylke Hoehnel-Ka
Sylke Hoehnel-Ka
MLMatthias Lutolf
Matthias Lutolf
Fate choices of stem cells are regulated in response to a complex array of biochemical and physical signals from their microenvironmental niche.

19 June 2024 in Biofabrication
Verified
Journal Article
Closed access
FPFrancesco Piraino
Francesco Piraino
MCMariana Costa
Mariana Costa
MMMarine Meyer
Marine Meyer
GCGeorgina Cornish
Georgina Cornish
CCCamilla Ceroni
Camilla Ceroni
NBNathalie Brandenberg
Nathalie Brandenberg
High failure rates of the current drug development process are driving exemplary changes toward methodologies centered on human disease in-vitro modeling. Organoids are self-organized tissue sub-units resembling their organ of origin and are widely acknowledged for their unique potential in recapitulating human physio-pathological mechanisms. They are transformative for human health by becoming the platform of choice to probe disease mechanisms and advance new therapies. Furthermore, the compounds’ validation as therapeutics represents another point of the drug development pipeline where organoids may provide key understandings and help pharma organizations replace or reduce animal research. In this review, we focus on gastrointestinal organoid models, which are currently the most advanced organoid models in drug development. We focus on experimental validations of their value, and we propose avenues to enhance their use in drug discovery and development, as well as precision medicine and diagnostics.

26 June 2015 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
SHSylke Hoehnel-Ka
Sylke Hoehnel-Ka
MLMatthias Lutolf
Matthias Lutolf